Vaccination for birch pollen allergy: Comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance

Clinical and Experimental Allergy

Volumn 35, Issue 2, 2005, Pages 193-198

  Jakobsen, Charlotte Georgi ^a,b,d   Bodtger, U ^c   Poulsen, L K ^c   Roggen, E L ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b NOVOZYMES A S   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Affinity; Allergen specific immunotherapy; Allergy; Bet v 1; IgE; IgG1; IgG4; Surface plasmon resonance

Indexed keywords

BET V 1 ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; POLLEN ANTIGEN; UNCLASSIFIED DRUG; VACCINE;

ADULT; ALLERGEN SPECIFIC IMMUNOTHERAPY; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; VACCINATION;

ADULT; ALLERGENS; ANTIBODIES, BLOCKING; ANTIBODY AFFINITY; CASE-CONTROL STUDIES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; POLLEN; STATISTICS, NONPARAMETRIC; SURFACE PLASMON RESONANCE;

EID: 14844351310     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02160.x     Document Type: Article

References (37)

1. Noon L, Cantab BC, Eng FRCS. Prophylactic inoculation against hay fever. Lancet 1911; 10:1572-3.
2. Akdis CA, Blaser K. Mechanisms of allergen-specific immunotherapy. Allergy 2000; 55:522-30.
3. Frew AJ. 25. Immunotherapy of allergic disease. J Allergy Clin Immunol 2003; 111:5712-9.
4. Cooke RA, Barnard JH, Hebald S, Stull A. Serological evidence of immunity with coexisting sensitization in a type of human allergy (hay fever). J Exp Med 1935; 62:733-50.
5. Loveless MH. Immunological studies of pollinosis: i. The presence of two antibodies related to the same pollen-antigen in the serum of treated hay-fever patients. J Immunol 1940; 38:25-50.
6. Pierson-Mullany LK, Jackola D, Blumenthal M, Rosenberg A. Altered allergen binding capacities of Amb a 1-specific IgE and IgG4 from ragweed-sensitive patients receiving immunotherapy. Ann Allergy Asthma Immunol 2000; 84:241-3.
7. Moverare R, Vesterinen E, Metso T, Sorva R, Elfman L, Haahtela T. Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations. Ann Allergy Asthma Immunol 2001; 86:337-42.
8. Nasser SM, Ying S, Meng Q, Kay AB, Ewan PW. Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. Eur J Immunol 2001; 31:3704-13.
9. Benjaponpitak S, Oro A, Maguire P, Marinkovich V, DeKruyff RH, Umetsu DT. The kinetics of change in cytokine production by CD4T cells during conventional allergen immunotherapy. J Allergy Clin Immunol 1999; 103:468-75.
10. Durham SR, Till SJ. Immunologie changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102:157-64.
11. Bellinghausen I, Brand U, Steinbrink K, Enk AH, Knop J, Saloga J. Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol 2001; 108:242-9.
12. Djukanovic R, Feather I, Gratziou C et al. Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms. Thorax 1996; 51:575-81.
13. Wilson DR, Irani AM, Walker SM et al. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy 2001; 31:1705-13.
14. Aleksza M, Lukacs A, Antal-Szalmas P, Hunyadi J, Szegedi A. Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis. Br J Dermatol 2002; 147:1135-41.
15. de Boer BA, Kruize YC, Yazdanbakhsh M. In vitro production of IgG4 by peripheral blood mononuclear cells (PBMC): the contribution of committed B cells. Clin Exp Immunol 1998; 114:252-7.
16. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998; 160:3555-61.
17. Duchateau J, Michils A, Michel O, Baras L. Mite allergy is associated with a specific profile of IgG epitopes recognized on antigen p1 of Dermatophagoides pteronyssinus. Clin Exp Allergy 1997; 27:296-305.
18. Michils A, Vervier I, Choufani G, Gossart B, Duchateau J. Relationship between allergic status and specificity of IgG antibody to inhaled allergens: the grass pollen model. Clin Exp Allergy 1999; 29:832-9.
19. Umetsu DT, DeKruyff RH. TH1 and TH2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 1997; 100:1-6.
20. Larsen JN, Spangfort MD, van Neerven RJJ, Ipsen H. Toward a unifying theory for the mechanism of Specific Allergy Vaccination. J Allergy Clin Immunol 2000; 105:5311.
21. Svenson M, Jacobi HH, Bodtger U, Poulsen LK, Rieneck K, Bendtzen K. Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1. Mol Immunol 2003; 39:603-12.
22. Bodtger U, Poulsen LK, Jacobi HH, Mailing HJ. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study. Allergy 2002; 57:297-305.
23. Varney VA, Gaga M, Frew AJ et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Br Med J 1991; 302:265-9.
24. Mothes N, Heinzkill M, Drachenberg KJ et al. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy 2003; 33:1198-208.
25. Wachholz PA, Soni NK, Till SJ, Durham SR. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 2003; 112:915-22.
26. Balda BR, Wolf H, Baumgarten C et al. Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens. Allergy 1998; 53:740-8.
27. Basomba A, Tabar AI, de Rojas DH et al. Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients. J Allergy Clin Immunol 2002; 109:943-8.
28. Chowdhury I, Chatterjee B. The immunological and clinical effects of immunotherapy in patients suffering from house dust allergy. Ann Agric Environ Med 1999; 6:91-7.
29. Jarolim E, Rumpold H, Endler AT et al. IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa. Allergy 1989; 44:385-95.
30. Niederberger V, Pauli G, Gronlund H et al. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations. J Allergy Clin Immunol 1998; 102:579-91.
31. Breiteneder H, Ferreira F, Hoffmann-Sommergruber K et al. Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding properties. Eur J Biochem 1993; 212:355-62.
32. Holm J, Baerentzen G, Gajhede M et al. Molecular basis of allergic cross-reactivity between group 1 major allergens from birch and apple. J Chromatogr B Biomed Sci Appl 2001; 756:307-13.
33. Lowenstein H, Sparholt SH, Klysner SS, Ipsen H, Larsen JN. The significance of isoallergenic variations in present and future specific immunotherapy. Int Arch Allergy Immunol 1995; 107:285-9.
34. Spangfort MD, Ipsen H, Sparholt SH et al. Characterisation of recombinant isoforms of birch pollen allergen Bet v 1. Adv Exp Med Biol 1996; 409:251-4.
35. Friedl-Hajek R, Radauer C, O'Riordain G et al. New Bet v 1 isoforms including a naturally occurring truncated form of the protein derived from Austrian birch pollen. Mol Immunol 1999; 36:639-45.
36. Swoboda I, Jilek A, Ferreira F et al. Isoforms of Bet v 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry, and cDNA cloning. J Biol Chem 1995; 270: 2607-13.
37. Van Regenmortel MH, Altschuh D, Chatellier J et al. Measurement of antigen-antibody interactions with biosensors. J Mol Recognit 1998; 11:163-7.